
Sign up to save your podcasts
Or


Professor Rob Doughty talks about a new combination medicine to New Zealand for the management of congestive heart failure - ‘Entresto’ Sacubitril/ Valsartan. Rob is a cardiologist and holds the Heart Foundation Chair in Heart Health at the University of Auckland. He practices at Auckland City Hospital where he is the leader of the heart failure service and privately at the Auckland Heart group.
By The Goodfellow Unit (University of Auckland)Professor Rob Doughty talks about a new combination medicine to New Zealand for the management of congestive heart failure - ‘Entresto’ Sacubitril/ Valsartan. Rob is a cardiologist and holds the Heart Foundation Chair in Heart Health at the University of Auckland. He practices at Auckland City Hospital where he is the leader of the heart failure service and privately at the Auckland Heart group.

7,907 Listeners

2,022 Listeners

1,393 Listeners

95 Listeners

3,367 Listeners

113,450 Listeners

275 Listeners

19 Listeners

4 Listeners

1,009 Listeners

7 Listeners

15,508 Listeners

3,880 Listeners

2,144 Listeners

913 Listeners